Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Olsson

Showing results (41-50 of 632) with videos related to

Pageof 64
Sort By:
Lakartidningen|April 23, 2004
[Apolipoprotein A-I can be a new tool in the treatment of atherosclerosis]Anders G Olsson
Acta Neurologica Scandinavica. Supplementum|July 27, 2006
The lower the better? Experiences from cardiovascular disease and stroke preventionA G Olsson
Clinical Therapeutics|January 11, 2007
Expanding options with a wider range of rosuvastatin dosesAnders G Olsson
Lakartidningen|November 14, 2009
[Warning for simvastatin 80 mg!]Anders G Olsson
Lakartidningen|February 11, 1987
[The strategy in the prevention of ischemic heart disease--European guidelines]A G Olsson
European Heart Journal|August 1, 1987
Angiographic evidence that treatment of lipoprotein abnormalities prevents progression of coronary atherosclerosisA G Olsson
Circulation|February 1, 1991
Regression of femoral atherosclerosisA G Olsson
F1000 Medicine Reports|December 22, 2010
Recent advances in preventing cardiovascular disorders by managing lipid levelsAnders G Olsson
Lakartidningen|June 3, 2005
[The TNT debate gives a lift to the debate about high-dose statins. Lower LDL cholesterol levels further reduce the cardiovascular risk]Anders G Olsson
Lakartidningen|November 20, 1998
[It is not easy to prove that monounsaturated fats protect against cardiovascular diseases. Different results in different populations]A G Olsson
Pageof 64

Showing results (41-50 of 632) with videos related to

Sort By:
Pageof 64
Lakartidningen|April 23, 2004
[Apolipoprotein A-I can be a new tool in the treatment of atherosclerosis]Anders G Olsson
Acta Neurologica Scandinavica. Supplementum|July 27, 2006
The lower the better? Experiences from cardiovascular disease and stroke preventionA G Olsson
Clinical Therapeutics|January 11, 2007
Expanding options with a wider range of rosuvastatin dosesAnders G Olsson
Lakartidningen|November 14, 2009
[Warning for simvastatin 80 mg!]Anders G Olsson
Lakartidningen|February 11, 1987
[The strategy in the prevention of ischemic heart disease--European guidelines]A G Olsson
European Heart Journal|August 1, 1987
Angiographic evidence that treatment of lipoprotein abnormalities prevents progression of coronary atherosclerosisA G Olsson
Circulation|February 1, 1991
Regression of femoral atherosclerosisA G Olsson
F1000 Medicine Reports|December 22, 2010
Recent advances in preventing cardiovascular disorders by managing lipid levelsAnders G Olsson
Lakartidningen|June 3, 2005
[The TNT debate gives a lift to the debate about high-dose statins. Lower LDL cholesterol levels further reduce the cardiovascular risk]Anders G Olsson
Lakartidningen|November 20, 1998
[It is not easy to prove that monounsaturated fats protect against cardiovascular diseases. Different results in different populations]A G Olsson
Pageof 64